1-Methyl-4-chloropiperidine hydrochloride, 95.0%, 5g

2,6-Dibromo-4-n-octyldithieno[3,2-b:2',3'-d]pyrrole>94.0%(GC)200mg

(3-Bromo-2-cyanophenyl)boronic acid, 97%, 10g

5-(2,4,6-trimethylphenyl)-1H-pyrazole, 95.0%, 1g

5-(difluoromethyl)-1,3,4-thiadiazol-2-amine, 95+%, 250mg

Tert-butyl 2,7-diazatricyclo[4.4.0.03,8]decane-2-carboxylate oxalate, 95%, 250mg

tert-butyl 4-(7-(2-(cyclopropylmethoxy)-6-((4-methoxybenzyl)oxy)phenyl)-2-oxo-2,4-dihydro-1H-pyrido[2,3-d][1,3]oxazin-5-yl)piperidine-1-carboxylate, 97%, 50mg

Methyl 6-bromoquinazoline-4-carboxylate, 95.0%, 5g

1-(2-Thiomorpholinoethyl)-1h-pyrazol-4-amine, 95%, 5g

(2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride, 97%, 5g

2-Chloro-5-nitrobenzo[d]oxazole, 95.0%, 250mg

Microliter syringe for HPLC, 500 µl, 1 piece

L-Phenylalanine methyl ester hydrochloride, 98.0%, 10g